Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 51.35 Delayed Data As of Jul 21 |  -0.70 / -1.34%Today’s Change | 35.79 Today|||52-Week Range 58.79 | -7.81% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 72.00, with a high estimate of 72.00 and a low estimate of 72.00. The median estimate represents a +40.21% increase from the last price of 51.35.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since July, when it was unchanged from a rating.Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.
